Zydus Looks To Revlimid Opportunity, Pivots To Multivariant COVID-19 Vaccine

Board Approves Share Buyback

 
• By Vibha Ravi
  
Mutating coronavirus
Evolving COVID-19 Situation Is Presenting Business Challenges • Source: Alamy

More from Strategy

More from Business